KEGG    Network variation - Cushing syndrome
[ Network menu | Network entry | Help ]
ENTRYnt06360
NameCushing syndrome
CategoryDisease view; Endocrine and metabolic disease
Pathwayhsa04934 Cushing syndrome
DiseaseH01431 Cushing syndrome
Display drug-target relation   disease type
CRH-ACTH signaling
N00324    CRHCRHRGNASADCYcAMPPKACREBACTH
N00325      RASD1*GNAIADCYcAMPPKACREBACTH
N00326        GNAS*ADCYcAMPPKACREBACTH
N00327    CRHCRHRGNASADCYcAMP(PRKAR1A*+PRKACA)CREBACTH
 
ACTH-cortisol signaling
              D1,D2
 |
  
N00297    ACTH(MC2R+MRAP)GNASADCYcAMPPKA(NR5A1,NR4A1,SP1,P..(STAR,CYP11B1)Cortisol
              D1,D2
 |
  
N00321        GNAS*ADCYcAMPPKA(NR5A1,NR4A1,SP1,P..(STAR,CYP11B1)Cortisol
              D1,D2
 |
  
N00323          (PDE11A*,PDE8B*)cAMP(PRKAR1A+PRKACA)(NR5A1,NR4A1,SP1,P..(STAR,CYP11B1)Cortisol
              D1,D2
 |
  
N00320              PRKACA*(NR5A1,NR4A1,SP1,P..(STAR,CYP11B1)Cortisol
              D1,D2
 |
  
N00322              (PRKAR1A*+PRKACA)(NR5A1,NR4A1,SP1,P..(STAR,CYP11B1)Cortisol
 
EGFR-ERK-ACTH signaling
N00318      EGFRERK1/2ACTH
N00319    USP8*EGFRERK1/2ACTH
 
Nuclear receptor signaling
N00317    KA(AHR+ARNT)(IL6,IL22,PTGS2,VE..
N00315    AIP*AHR
N00290        (MEN1*+KMT2A)(CDKN1B,CDKN2C)
N00316          CDKN1B*(CCNE+CDK2)RB1E2F


Drug name
D1D00410Metyrapone (JP18/USP/INN)
D2D10950Levoketoconazole (USAN/INN)